Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 4 2 5 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 4 2 5 IN PLASTIC CONTAINER versus PRISMASOL BK 0 0 IN PLASTIC CONTAINER.
PRISMASOL B22GK 4/2.5 IN PLASTIC CONTAINER vs PRISMASOL BK 0/0 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK 4/2.5 is a hemofiltration solution used for continuous renal replacement therapy (CRRT). It provides electrolytes and buffer to correct metabolic acidosis and maintains electrolyte balance while removing waste products via convective and diffusive clearance.
Prismasol BK 0/0 is a sterile, nonpyrogenic bicarbonate-buffered replacement solution for continuous renal replacement therapy (CRRT). It acts as an electrolyte and buffer replacement to correct acid-base disturbances and maintain fluid balance during hemofiltration, with no pharmacologic active drug component.
Continuous renal replacement therapy (CRRT) solution; dosing based on prescribed effluent rate, typically 20-35 mL/kg/h. Route: intravenous via CRRT circuit.
Administered as a continuous infusion at rates typically between 1000-4000 mL/hour depending on the desired effluent flow rate, patient fluid balance, and metabolic requirements. The solution is used as dialysate (hemodiafiltration) or replacement fluid (hemofiltration). Must be prescribed and administered under physician supervision using intravenous infusion via a dialyzer or hemofilter.
None Documented
None Documented
Not applicable as a dialysis solution. Individual components have varying half-lives: glucose ~1.5-2 h, lactate ~0.5-1.5 h, electrolytes depend on renal function.
Not applicable; PRISMASOL is a dialysate solution, not a drug with systemic absorption; components are removed by dialysis.
PRISMASOL B22GK 4/2.5 is a hemodialysis solution; its components are primarily removed via dialysis. Electrolytes and lactate are eliminated renally in patients with residual function, but in ESRD, clearance is via dialysis. Glucose is metabolized or removed by dialysis.
Renal (80-100% in urine as unabsorbed, not metabolized); minimal biliary/fecal.
Category C
Category C
Dialysis Solution
Dialysis Solution